The watermelon frost king died of illness.
At noon on December 22, Zou Jieming, the actual controller and chairman (and legal representative) of the company, died of illness on December 21 at the age of 80.
As one of the earliest manufacturers of modern traditional Chinese medicine preparations in China, Guilin Sanjin Pharmaceutical Co.Ltd(002275) Sanjin watermelon cream series products have always been well-known.
Zou Jieming once summed up the road he and Sanjin have taken: “in fact, I have only done one thing, that is to explore and innovate the road of modern traditional Chinese medicine with Guilin Sanjin Pharmaceutical Co.Ltd(002275) .”
Guilin Sanjin Pharmaceutical Co.Ltd(002275) said that as the main founder, Zou Jieming worked hard for the establishment, growth and development of the company, devoted his whole life and made indelible contributions to the development of the company. At present, the company’s production and operation activities remain stable and normal, and will timely perform the obligation of information disclosure according to the progress of follow-up matters.
soul character dies
At noon on December 22, Guilin Sanjin Pharmaceutical Co.Ltd(002275) the board of directors announced that Zou Jieming, the actual controller and chairman (and legal representative) of the company, died of illness on December 21 at the age of 80.
It is understood that Zou Jieming directly holds Guilin Sanjin Pharmaceutical Co.Ltd(002275) 9.05% equity, and directly or indirectly holds 41.80% equity of the company through himself and his relatives. He is the actual controller of the company.
Guilin Sanjin Pharmaceutical Co.Ltd(002275) said that Zou Jieming, as the main founder of the company, devoted himself to the establishment, growth and development of the company and devoted his whole life to the development of the company. During his tenure as chairman of the company, Zou Jieming scrupulously performed his duties, performed his duties diligently, faithfully and honestly, and played a positive role in the standardized operation and high-quality development of the company. The board of directors of the company pays high tribute to Zou Jieming for his contribution and efforts to the development of the company during his tenure. The directors, supervisors, senior managers and all employees of the company expressed deep condolences on Zou Jieming’s death and expressed deep condolences to his family members.
Guilin Sanjin Pharmaceutical Co.Ltd(002275) said that at present, the company’s production and operation activities remain stable and normal, and all employees of the company will continue to be diligent and responsible and committed to the long-term development of the company. The company will timely perform the obligation of information disclosure according to the progress of subsequent matters.
The Chinese reporter of the brokerage noted that on that day, Guilin Sanjin Pharmaceutical Co.Ltd(002275) official website had become black and white. According to the obituary, Zou Jieming’s farewell ceremony will be held on December 25.
According to public information, Guilin Sanjin Pharmaceutical Co.Ltd(002275) is the core enterprise of Sanjin group. It is mainly engaged in the R & D and production of Chinese patent medicine and natural drugs. It is one of the earliest manufacturers of modern traditional Chinese medicine preparations in China. Sanjin has more than 200 registered varieties and 13 drug dosage forms, and 42 exclusive characteristic varieties independently developed by Guilin Watermelon cream, watermelon cream throat moistening tablets, Sanjin tablets and Naomaitai capsules, among which Sanjin watermelon cream series and Sanjin tablets, the representative products, have been in the forefront of similar Chinese patent medicines in China for many years.
In July 2009 ” Guilin Sanjin Pharmaceutical Co.Ltd(002275) ” was listed on Shenzhen Stock Exchange. According to the third quarterly report of 2021, the operating revenue of Guilin Sanjin Pharmaceutical Co.Ltd(002275) in the first three quarters of this year was RMB 1.256 billion, a year-on-year increase of 14.37%, and the net profit attributable to the parent company was RMB 293 million, a year-on-year decrease of 3.98%.
“only do one thing in your life”
Zou Jieming once summed up his years with Sanjin in this sentence: “in fact, I only did one thing, that is to explore the road of innovating modern traditional Chinese medicine with Guilin Sanjin Pharmaceutical Co.Ltd(002275) .”
According to his resume, he graduated from the Department of biology of Wuhan University in July 1966, majoring in medicinal plants, and then studied traditional Chinese medicine for two years. After graduation, he participated in the preparation for the establishment of Guilin traditional Chinese medicine factory ( Guilin Sanjin Pharmaceutical Co.Ltd(002275) ). He once served as a technician, director of the research office and Deputy technical director of the factory. He served as the factory director and chief engineer since December 1984, and later served as the chairman and Secretary of the Party committee of Guilin Sanjin Pharmaceutical Co.Ltd(002275) .
According to Guilin evening news and Netease Guilin, as early as the late 1960s, Zou Jieming became an ordinary worker in Guilin traditional Chinese medicine factory ( Guilin Sanjin Pharmaceutical Co.Ltd(002275) predecessor) and was the only college student in the factory. At that time, the traditional Chinese medicine factory was only a small workshop with 30 or 40 people. It followed the traditional production method of boiling wax to make shells and refining honey to pills, and there was no pharmaceutical equipment. In this environment, Zou Jieming continued research and development to optimize and innovate the existing products of the traditional Chinese medicine factory. Later, the traditional Chinese medicine factory became one of the earliest manufacturers of traditional Chinese medicine tablets and granules in China at that time. The initial varieties of Yinqiao Jiedu Tablets, Andrographis paniculata tablets, Sangju Ganmao tablets and loquat cough granules were affirmed by the industry.
The above media reported that in the 1970s, on a business trip, Zou Jieming met an old man with several bags of medicine. The other party said that the effect of treating urinary tract infection was very good. Zou Jieming inspected the medicinal materials and found that there were three main drugs, which were the same as a decoction prescription he saw when consulting the medical literature. After returning to Guilin, he began to study. After three years, he successfully developed Sanjin tablet, a good medicine for the treatment of urinary tract infection. The drug won the scientific and Technological Achievement Award at the National Science Conference in 1978. Guilin traditional Chinese medicine factory and Zou Jieming gained a reputation in the same industry in China.
He then began to study watermelon cream. It is understood that in the 1970s, enterprises manufacturing watermelon cream according to traditional processes stopped production one after another, mainly because the processing of watermelon cream according to the ancient method had complex procedures, especially long frost time, great impact by climate, low frost yield, high cost and no energy production. After continuous research and improvement, Zou Jieming’s original production cycle of 8-10 months was shortened to 5-7 days, and there was no seasonality in production. Sanjin became the only enterprise outside China to realize the industrialized production of watermelon frost.
Zou Jieming once said that the ingenuity spirit of “persistence, inheritance and innovation” is the gene most valued by Sanjin people, the secret of Sanjin’s success in the past 50 years, and the secret key to building a century old famous enterprise in the future.
who will take over in the future?
Who will steer Guilin Sanjin Pharmaceutical Co.Ltd(002275) in the future has not been answered yet.
From the perspective of equity structure, according to the 2020 annual report, Guilin Sanjin Pharmaceutical Co.Ltd(002275) group is the major shareholder, holding 61.33%, Zou Jieming directly holding 9.05%, and his wife Weng Yuling directly holding 0.88%. Zou Jieming family holds about 82% of the shares of Guilin Sanjin Pharmaceutical Co.Ltd(002275) group. The closing price of Guilin Sanjin Pharmaceutical Co.Ltd(002275) on December 22 was 16.88 yuan, up 5.17%. Based on this calculation, the market value of Zou Jieming and his relatives’ shares reached 4.164 billion yuan.
Zou Xun and Zou Zhun, Zou Jieming’s two sons, did not directly hold Guilin Sanjin Pharmaceutical Co.Ltd(002275) , but worked in Guilin Sanjin Pharmaceutical Co.Ltd(002275) for more than ten years. According to public information, his son Zou Xun was born in 1976 and graduated from Nanjing University of technology with a bachelor’s degree in accounting. Later, he had many experience in studying abroad. He studied at the University of New England with a master’s degree in international business in 2002 and at Griffith University in Australia with a master’s degree in accounting and finance in 2003. He joined Guilin Sanjin Pharmaceutical Co.Ltd(002275) in October 2007 and successively served as the office administrator of the board of directors, assistant to the general manager, assistant to the president, executive director of Guilin Jinke Health Products Co., Ltd. he is now the director of Guilin Sanjin Pharmaceutical Co.Ltd(002275) , vice chairman, executive vice president and Secretary of the board of directors.
Zou Zhun, another son, was born in 1980 and graduated from Wuhan University with a bachelor’s degree in biotechnology. From 2004 to 2007, he studied at the University of Queensland, Australia and obtained a master’s degree and MBA in biotechnology. He joined Guilin Sanjin Pharmaceutical Co.Ltd(002275) in April 2010. He has successively served as a researcher of the Pharmaceutical Research Institute, regional marketing director and President Assistant of the marketing headquarters. He is now a director, Guilin Sanjin Pharmaceutical Co.Ltd(002275) director and vice president of Guilin Sanjin Pharmaceutical Co.Ltd(002275) Group Co., Ltd.
In addition to relatives, Guilin Sanjin Pharmaceutical Co.Ltd(002275) there are two veteran figures, namely president Wang Xufei and Vice President Xie Yuangang.
It is understood that Wang Xufei was born in 1958 and graduated from the Department of pharmacy of Guangxi University of traditional Chinese medicine with a Bachelor of medicine. He began to work in Guilin traditional Chinese medicine factory in 1984 and successively served as technician, director of production section, director of technology section, director of sales section, assistant to factory director, deputy factory director, director, vice president, financial director, etc. It has successively won the honors of national model worker, Guangxi model worker and Guilin excellent entrepreneur. He is currently the managing director of Guilin Sanjin Pharmaceutical Co.Ltd(002275) Group Co., Ltd., vice chairman and President of the company.
Xie Yuangang, born in 1961, graduated from Guangxi University of traditional Chinese medicine with a bachelor’s degree in medicine in 1982. In the same year, he entered Guilin traditional Chinese medicine factory. He successively served as the company’s quality inspector, director of quality inspection department, director of enterprise management office, director of marketing department, vice president of the board of directors and financial director, and successively won the honors of Guilin model worker and Guangxi model worker. He is currently a director of Guilin Sanjin Pharmaceutical Co.Ltd(002275) Group Co., Ltd., a director, vice president and financial director of the company.
(brokerage China)
